Nabil Adra
-
- Sarcoma Diagnosis and Treatment 34
- Prostate Cancer Treatment and Research 24
- Reproductive Medicine top 5%
- Surgery top 5%
- Testicular diseases and treatments 65
- Bladder and Urothelial Cancer Treatments 16
- Urinary and Genital Oncology Studies 10
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 18
- Neurology top 5%
- Neuroblastoma Research and Treatments 28
-
- Radiopharmaceutical Chemistry and Applications 12
- Co-authors
- Lawrence H. EinhornNasser H. HannaCostantine AlbanySandra K. AlthouseRafat AbonourDavid J. VaughnNatraj Reddy AmmakkanavarClint Cary
- Journals
- Journal of Clinical Oncology (60 papers)Clinical Genitourinary Cancer (8 papers)Annals of Oncology (6 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Nabil Adra
104 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 81
- Pulmonary and Respiratory Medicine 622
- Reproductive Medicine 153
- Surgery 757
- Oncology 460
- Neurology 232
Countries citing papers authored by Nabil Adra
This map shows the geographic impact of Nabil Adra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nabil Adra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nabil Adra more than expected).
Fields of papers citing papers by Nabil Adra
This network shows the impact of papers produced by Nabil Adra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nabil Adra. The network helps show where Nabil Adra may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nabil Adra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 8 | |
| 13 | 2022 | 15 | |
| 14 | 2022 | 1 | |
| 15 | 2022 | 4 | |
| 16 | 2022 | 1 | |
| 17 | 2021 | 0 | |
| 18 | 2020 | 30 | |
| 19 | 2020 | 8 | |
| 20 | 2019 | 4 |
About Nabil Adra
Nabil Adra is a scholar working on Pulmonary and Respiratory Medicine, Neurology, Surgery, Oncology and Reproductive Medicine, having authored 119 papers that have together received 1.4k indexed citations. Recurring topics across this work include Testicular diseases and treatments (65 papers), Sarcoma Diagnosis and Treatment (34 papers), Neuroblastoma Research and Treatments (28 papers), Prostate Cancer Treatment and Research (24 papers), Cancer Immunotherapy and Biomarkers (18 papers), Bladder and Urothelial Cancer Treatments (16 papers), Radiopharmaceutical Chemistry and Applications (12 papers) and Urinary and Genital Oncology Studies (10 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (622 citations), Reproductive Medicine (153 citations), Surgery (757 citations), Oncology (460 citations) and Neurology (232 citations). Nabil Adra has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Lawrence H. Einhorn, Nasser H. Hanna, Costantine Albany, Sandra K. Althouse, Rafat Abonour, David J. Vaughn, Natraj Reddy Ammakkanavar, Clint Cary, Timothy A. Masterson and Роберто Пили. Their work appears in journals such as Journal of Clinical Oncology, Clinical Genitourinary Cancer, Annals of Oncology, Urologic Oncology Seminars and Original Investigations and Current Opinion in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.